We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Indivior Plc | LSE:INDV | London | Ordinary Share | GB00BN4HT335 | ORD USD0.50 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
25.50 | 2.65% | 987.00 | 994.50 | 1,004.00 | 1,013.00 | 958.00 | 1,001.00 | 973,842 | 16:35:01 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 1.09B | 2M | 0.0147 | 673.47 | 1.31B |
Date | Subject | Author | Discuss |
---|---|---|---|
26/7/2024 22:35 | couple of NED buys | tsmith2 | |
26/7/2024 10:30 | Gap closed | sbb1x | |
26/7/2024 10:11 | Presentation makes for good listening | tsmith2 | |
26/7/2024 08:28 | Thanks Waldron. The average target price on MarketScreener is indicated as about double what it is trading for just now. | casholaa | |
25/7/2024 21:50 | US closed at $13.09 - 1018p | casholaa | |
25/7/2024 21:34 | Yeah we need another 50p rise to catch up tomorrow morning | youngers | |
25/7/2024 21:00 | good rise on good volume in states | tsmith2 | |
25/7/2024 14:44 | Glad to see we're back over a tenner. The Nasdaq buyers have now had their cheap entry as arranged by the powers that be. | swinsco | |
25/7/2024 10:37 | "The specialty pharmaceuticals business said revenue in the first-half of the year improved 10% to USD583 million from USD529 million. It swung to a pretax loss, however, of USD72 million from profit of USD120 million. Its second-quarter revenue rose 8.3% to USD299 million from USD276 million, but it posted a loss of USD135 million, swinging from profit of USD62 million. Selling, general, and administrative expenses in the quarter jumped to USD311 million from USD133 million. The figure includes costs related to a legal settlement, its US primary listing and the hit from the discontinuation of schizophrenia drug Perseris, announced earlier in July. " | casholaa | |
25/7/2024 09:19 | well, its much better than I feared. Possibly I will be more selective next time and pick the dodgems. The big dipper syndrome is quite an investment experience! | gregmorg | |
25/7/2024 08:29 | Look at cabp | sbb1x | |
25/7/2024 08:18 | That's me out. Thank you | imjustdandy | |
25/7/2024 08:12 | Still needs to gapfill at around 1160p mark. | casholaa | |
25/7/2024 08:07 | Nice open. | casholaa | |
25/7/2024 07:36 | Funny how the $160m provision wasn't mentioned 2 weeks ago. Apart from that, nothing new. Accelerated buy backs should put a floor on the Share Price | hunter154 | |
25/7/2024 07:35 | No nasty surprises from what I can see | casholaa | |
25/7/2024 07:16 | All seems in order | imjustdandy | |
25/7/2024 07:14 | reassuring update and accelerated buy back announced :) | tsmith2 | |
24/7/2024 18:41 | Casholaa 24 Jul '24 - 18:35 - 4031 of 4031 0 0 0 | waldron | |
24/7/2024 18:35 | https://www.asktrade | casholaa | |
24/7/2024 18:11 | I'm all in for tomorrow | imjustdandy |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions